SERA

Sera Prognostics Inc

SERA.US sera.com + Research + Basket
CIK 0001534969
Employees 71
Phone 801 990 0520
Fiscal year end December
IPO Jul 15, 2021
Address 2749 East Parleys Way, Salt Lake City, UT, United States, 84109
2.03
-0.02 (-0.98%)
USD · NASDAQ
52-week range
1.56
3.85
Trading at 21% of the 52-week range
Market Cap
80.48M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
1.51
Div. Yield
N/A
% Institutions
57.30%
% Insiders
12.11%

1 Year

-45.9%

3 Year

+17.3%

10 Year

-82.9%
Description

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Actions

Add an action for SERA.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Ms. Zhenya Lindgardt M.B.A. President, CEO & Director 1974
Dr. John J. Boniface Ph.D. Chief Scientific Officer 1962
Dr. Gregory C. Critchfield M.D., M.S. Executive Director 1953
Dr. Paul Kearney Ph.D. Chief Data Officer 1968
Mr. Scott Gleason CFO & Treasurer 1979
Mr. Robert G. Harrison Chief Information Officer 1966
Ms. Jennifer Zibuda Head of Investor Relations NA
Mr. Benjamin G. Jackson J.D. General Counsel & Corporate Secretary 1979
Mr. Austin Aerts Advisor 1987
Mr. Lee Anderson Chief Commercial Officer NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 11, 2026 Austin Aerts N/A Sale 1.02K $2.04 $2.08K SEC
Mar 11, 2026 Zhenya Lindgardt N/A Sale 2.97K $2.04 $6.06K SEC
Mar 11, 2026 Robert Gardner Harrison N/A Sale 716.00 $2.04 $1.46K SEC
Mar 11, 2026 John J Boniface N/A Sale 1.52K $2.04 $3.09K SEC
Mar 11, 2026 Paul Kearney N/A Sale 1.40K $2.04 $2.85K SEC
Mar 11, 2026 Benjamin Jackson N/A Sale 1.03K $2.04 $2.10K SEC
Mar 10, 2026 Austin Aerts N/A Sale 6.07K $1.90 $11.53K SEC
Mar 10, 2026 Zhenya Lindgardt N/A Sale 22.64K $1.90 $43.01K SEC
Mar 09, 2026 Robert Gardner Harrison N/A Sale 3.36K $1.96 $6.59K SEC
Mar 09, 2026 Paul Kearney N/A Sale 2.03K $1.96 $3.97K SEC
Mar 09, 2026 Benjamin Jackson N/A Sale 3.12K $1.96 $6.11K SEC
Mar 09, 2026 Austin Aerts N/A Sale 674.00 $1.96 $1.32K SEC
Mar 09, 2026 John J Boniface N/A Sale 3.04K $1.96 $5.95K SEC
Mar 06, 2026 Sandra Aj Lawrence N/A Sale 1.56K $1.95 $3.04K SEC
Feb 24, 2026 Robert Gardner Harrison N/A Sale 2.00K $2.34 $4.68K SEC
Jan 27, 2026 Robert Gardner Harrison N/A Sale 2.00K $2.97 $5.94K SEC
Dec 30, 2025 Robert Gardner Harrison N/A Sale 2.00K $3.00 $6.00K SEC
Dec 10, 2025 Zhenya Lindgardt N/A Sale 4.16K $3.31 $13.75K SEC
Dec 10, 2025 Robert Gardner Harrison N/A Sale 616.00 $3.31 $2.04K SEC
Dec 10, 2025 Austin Aerts N/A Sale 873.00 $3.31 $2.89K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 5.50M Jun 30, 2026 13.94% $0.05 0.00%
Whetstone Capital Advisors, LLC 3.31M Jun 30, 2026 8.38% $1.58 0.00%
Aberdeen Group PLC 2.75M Jun 30, 2026 6.98% $0.01 7.95%
Vivo Capital, LLC 1.65M Jun 30, 2026 4.18% $0.27 0.00%
Vanguard Capital Management, LLC 1.30M Jun 30, 2026 3.29% $0.00 7.78%
CapTrust Financial Advisors 535.76K Jun 30, 2026 1.36% $0.00 -0.19%
Geode Capital Management, LLC 348.97K Jun 30, 2026 0.88% $0.00 -4.03%
BlackRock Inc 221.37K Jun 30, 2026 0.56% $0.00 12.88%
Awm Investment Company Inc 207.38K Jun 30, 2026 0.53% $0.03 0.00%
Vanguard Fiduciary Trust Co 170.91K Jun 30, 2026 0.43% $0.00 0.74%
State Street Corp 124.79K Jun 30, 2026 0.32% $0.00 0.00%
Millennium Management LLC 73.99K Jun 30, 2026 0.19% $0.00 -19.14%
Perigon Wealth Management, LLC 72.69K Jun 30, 2026 0.18% $0.00 0.00%
Northern Trust Corp 68.60K Jun 30, 2026 0.17% $0.00 -28.94%
Bank of New York Mellon Corp 60.93K Jun 30, 2026 0.15% $0.00 0.00%
Bridgeway Capital Management, LLC 55.71K Jun 30, 2026 0.14% $0.00 21.88%
Requisite Capital Management, LLC 55.65K Jun 30, 2026 0.14% $0.02 0.00%
Morgan Stanley - Brokerage Accounts 50.97K Jun 30, 2026 0.13% $0.00 -51.46%
Qube Research & Technologies 50.87K Jun 30, 2026 0.13% $0.00 155.42%
Ballentine Finn & Company Inc 49.66K Jun 30, 2026 0.13% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 abrdn Healthcare Opportunities 1.48M 3.76% ▲ 3.80% Sep 30, 2026
2 abrdn Healthcare Investors 1.43M 3.63% ▲ 0.00% Sep 30, 2026
3 Vanguard MStar Total Stk Mkt Idx Invest 887.02K 2.25% ▲ 0.00% Sep 30, 2026
4 Fidelity Extended Market Index 161.36K 0.41% ▼ 0.53% Aug 31, 2026
5 iShares Micro-Cap ETF 104.36K 0.26% ▼ 0.69% Sep 30, 2026
6 Fidelity Total Market Index 50.64K 0.13% ▲ 0.00% Aug 31, 2026
7 EA Bridgeway Ultra-Small Company Mkt ETF 50.44K 0.13% ▲ 0.00% Sep 30, 2026
8 Fidelity Series Total Market Index 47.34K 0.12% ▲ 0.00% Aug 31, 2026
9 Goldman Sachs Absolute Ret Trckr Instl 21.84K 0.06% ▼ 8.04% Jun 30, 2026
10 Fidelity Nasdaq Composite Index 18.95K 0.05% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $80.48M
EBITDA: $-36.54M
Book Value: $1.51
Earnings/Share: $-0.67
Profit Margin: 0.00%
Operating Margin: -33,346.67%
ROA (TTM): -23.48%
ROE (TTM): -45.03%
Revenue (TTM): $70.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 76.50%

Valuation Metrics

Enterprise Value: $36.64M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 38.48M
Shares Float: 27.70M
% Insiders: 12.11%
% Institutions: 57.30%
Short % Float: 0.73%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$81.00K
Cost of Goods Sold
adjust
$-164.00K
Gross Profit
subtotal
$-83.00K
SG&A
adjust
$-16.70M
R&D
adjust
$-13.17M
Other Operating Expense
adjust
$-6.55M
Operating Income
subtotal
$-36.50M
Other / Non-Operating Items
adjust
$4.58M
Net Income
subtotal
$-31.93M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SERA.US!